XBIO vs IMMX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

XBIO

51.6
AI Score
VS
IMMX Wins

IMMX

58.4
AI Score

Investment Advisor Scores

XBIO

52score
Recommendation
HOLD

IMMX

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XBIO IMMX Winner
Revenue 2.98M 20.00M IMMX
Net Income -2.68M -10.09M XBIO
Net Margin -90.1% -50.4% IMMX
Operating Income -2.83M -10.80M XBIO
ROE -36.2% -12.0% IMMX
ROA -32.1% -10.5% IMMX
Total Assets 8.36M 95.82M IMMX
Cash 7.88M 79.25M IMMX
Current Ratio 8.32 8.76 IMMX

Relative Price Performance (Last 90 Days)

XBIO 1M: -4.0% · 3M: -10.4% IMMX 1M: -18.6% · 3M: -9.5%

Current Technical Phase

XBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $2.66

IMMX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.2 · Price: $8.42

Fundamentals Snapshot

Metric XBIO IMMX
Market Cap
Forward P/E -7.8 -10.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% 0.0%
Gross Margin 1.0%
Operating Margin -0.6% 0.0%
EPS -1.19 -0.92
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IMMX is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.